nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—Mepyramine—SLC22A4—Crohn's disease	0.112	0.494	CrCbGaD
Brompheniramine—Mepyramine—SLC22A5—Crohn's disease	0.084	0.371	CrCbGaD
Brompheniramine—Diphenhydramine—SLC22A5—Crohn's disease	0.0306	0.135	CrCbGaD
Brompheniramine—HRH1—Signaling by GPCR—CCR6—Crohn's disease	0.000684	0.000884	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000682	0.000881	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CCR6—Crohn's disease	0.00068	0.000879	CbGpPWpGaD
Brompheniramine—CHRM2—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000675	0.000872	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CCR6—Crohn's disease	0.000673	0.00087	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SEL1L—Crohn's disease	0.000667	0.000862	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SEL1L—Crohn's disease	0.000665	0.000859	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000663	0.000857	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SEL1L—Crohn's disease	0.000663	0.000857	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000661	0.000855	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—PTGER4—Crohn's disease	0.000659	0.000852	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SEL1L—Crohn's disease	0.000656	0.000848	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000653	0.000844	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR ligand binding—CXCL8—Crohn's disease	0.000635	0.000821	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—FADS1—Crohn's disease	0.000634	0.000819	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	0.000622	0.000804	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCR9—Crohn's disease	0.00061	0.000789	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR ligand binding—CXCL8—Crohn's disease	0.000608	0.000786	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCR9—Crohn's disease	0.000608	0.000786	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCR9—Crohn's disease	0.000606	0.000784	CbGpPWpGaD
Brompheniramine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000606	0.000783	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—PTGER4—Crohn's disease	0.000602	0.000779	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.0006	0.000776	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCR9—Crohn's disease	0.0006	0.000776	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—PTGER4—Crohn's disease	0.000599	0.000774	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CCR6—Crohn's disease	0.000598	0.000772	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—GPX4—Crohn's disease	0.000593	0.000767	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—PTGER4—Crohn's disease	0.000593	0.000766	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—MTMR3—Crohn's disease	0.000592	0.000766	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—IL2RA—Crohn's disease	0.000585	0.000756	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—GCKR—Crohn's disease	0.000573	0.000741	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CCR6—Crohn's disease	0.000572	0.00074	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	0.000572	0.000739	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—GPR65—Crohn's disease	0.000567	0.000733	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	0.000567	0.000733	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—GPR65—Crohn's disease	0.000565	0.000731	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—IL3—Crohn's disease	0.000565	0.00073	CbGpPWpGaD
Brompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000564	0.000729	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—GPR65—Crohn's disease	0.000564	0.000728	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—IL3—Crohn's disease	0.000563	0.000728	CbGpPWpGaD
Brompheniramine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000562	0.000727	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—IL3—Crohn's disease	0.000561	0.000726	CbGpPWpGaD
Brompheniramine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000561	0.000725	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—IL2RA—Crohn's disease	0.00056	0.000724	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—GPR65—Crohn's disease	0.000558	0.000721	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—IL3—Crohn's disease	0.000556	0.000719	CbGpPWpGaD
Brompheniramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000555	0.000718	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000546	0.000706	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—FADS1—Crohn's disease	0.000545	0.000705	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000545	0.000704	CbGpPWpGaD
Brompheniramine—CHRM2—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000544	0.000704	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000543	0.000702	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—RBX1—Crohn's disease	0.00054	0.000698	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000538	0.000695	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—FADS1—Crohn's disease	0.000534	0.00069	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—IL2RA—Crohn's disease	0.000531	0.000687	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—MTMR3—Crohn's disease	0.000529	0.000684	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PTGER4—Crohn's disease	0.000526	0.00068	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—RBX1—Crohn's disease	0.000517	0.000669	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL3—Crohn's disease	0.000513	0.000663	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL3—Crohn's disease	0.000511	0.000661	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GPX4—Crohn's disease	0.000511	0.00066	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL3—Crohn's disease	0.00051	0.000659	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL2RA—Crohn's disease	0.000509	0.000658	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL3—Crohn's disease	0.000505	0.000653	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PTGER4—Crohn's disease	0.000504	0.000651	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GPX4—Crohn's disease	0.0005	0.000646	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000496	0.000641	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000495	0.000639	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—RASGRP1—Crohn's disease	0.000493	0.000637	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GCKR—Crohn's disease	0.000493	0.000637	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000488	0.000631	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—MTMR3—Crohn's disease	0.000486	0.000629	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GCKR—Crohn's disease	0.000483	0.000624	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—MTMR3—Crohn's disease	0.000482	0.000623	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—UBE2D1—Crohn's disease	0.000474	0.000612	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—FADS1—Crohn's disease	0.000462	0.000597	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—RIPK2—Crohn's disease	0.000459	0.000594	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—UBE2D1—Crohn's disease	0.000454	0.000586	CbGpPWpGaD
Brompheniramine—CHRM1—Circadian rythm related genes—IL6—Crohn's disease	0.00045	0.000582	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL3—Crohn's disease	0.000448	0.000579	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—RIPK2—Crohn's disease	0.00044	0.000569	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—RASGRP1—Crohn's disease	0.000433	0.00056	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GPX4—Crohn's disease	0.000432	0.000559	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—CXCL8—Crohn's disease	0.00043	0.000555	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL3—Crohn's disease	0.000429	0.000555	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—CXCL8—Crohn's disease	0.000428	0.000554	CbGpPWpGaD
Brompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000428	0.000553	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—CXCL8—Crohn's disease	0.000427	0.000552	CbGpPWpGaD
Brompheniramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000427	0.000551	CbGpPWpGaD
Brompheniramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000425	0.00055	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—CXCL8—Crohn's disease	0.000423	0.000546	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GCKR—Crohn's disease	0.000417	0.00054	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—RASGRP1—Crohn's disease	0.000415	0.000536	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—FADS1—Crohn's disease	0.000412	0.000532	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCR6—Crohn's disease	0.000404	0.000522	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCR6—Crohn's disease	0.000403	0.000521	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCR6—Crohn's disease	0.000402	0.000519	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCR6—Crohn's disease	0.000398	0.000514	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000396	0.000512	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000395	0.00051	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—JAK2—Crohn's disease	0.000393	0.000508	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—IL2RA—Crohn's disease	0.000393	0.000508	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—SOCS1—Crohn's disease	0.000393	0.000507	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000389	0.000503	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GPX4—Crohn's disease	0.000386	0.000499	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—FADS1—Crohn's disease	0.000379	0.00049	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—JAK2—Crohn's disease	0.000377	0.000487	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—SOCS1—Crohn's disease	0.000376	0.000486	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—FADS1—Crohn's disease	0.000376	0.000486	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—TYK2—Crohn's disease	0.000374	0.000484	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	0.000374	0.000483	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GCKR—Crohn's disease	0.000373	0.000482	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RBX1—Crohn's disease	0.000366	0.000472	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RBX1—Crohn's disease	0.000364	0.000471	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RBX1—Crohn's disease	0.000363	0.000469	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RBX1—Crohn's disease	0.00036	0.000465	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL2RA—Crohn's disease	0.000359	0.000465	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—CXCL8—Crohn's disease	0.000359	0.000464	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—TYK2—Crohn's disease	0.000358	0.000463	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.000358	0.000463	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—JAK2—Crohn's disease	0.000357	0.000462	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL2RA—Crohn's disease	0.000357	0.000462	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PTGER4—Crohn's disease	0.000356	0.00046	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GPX4—Crohn's disease	0.000355	0.000459	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	0.000355	0.000458	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	0.000354	0.000457	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PTGER4—Crohn's disease	0.000354	0.000457	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GPX4—Crohn's disease	0.000352	0.000455	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	0.00035	0.000453	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—CXCL8—Crohn's disease	0.000344	0.000444	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GCKR—Crohn's disease	0.000343	0.000443	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—JAK2—Crohn's disease	0.000342	0.000442	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GCKR—Crohn's disease	0.00034	0.000439	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—SMAD3—Crohn's disease	0.000339	0.000438	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—CXCL8—Crohn's disease	0.000326	0.000421	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—SMAD3—Crohn's disease	0.000325	0.00042	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	0.000321	0.000414	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.000319	0.000413	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—UBE2D1—Crohn's disease	0.000318	0.000412	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MTMR3—Crohn's disease	0.000318	0.000411	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	0.000315	0.000408	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL2RA—Crohn's disease	0.000314	0.000406	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—CXCL8—Crohn's disease	0.000312	0.000403	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RIPK2—Crohn's disease	0.000311	0.000402	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	0.00031	0.0004	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RIPK2—Crohn's disease	0.000309	0.000399	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	0.000306	0.000395	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL3—Crohn's disease	0.000303	0.000392	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL3—Crohn's disease	0.000302	0.00039	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL3—Crohn's disease	0.000301	0.000389	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL2RA—Crohn's disease	0.000301	0.000388	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000298	0.000386	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL3—Crohn's disease	0.000298	0.000385	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	0.000293	0.000379	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	0.000292	0.000378	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	0.000291	0.000376	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	0.000288	0.000373	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000266	0.000344	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	0.000266	0.000344	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SOCS1—Crohn's disease	0.000266	0.000343	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	0.000265	0.000343	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	0.000265	0.000342	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	0.000264	0.000342	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	0.000264	0.000341	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	0.000262	0.000338	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	0.000261	0.000338	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000261	0.000337	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—TYK2—Crohn's disease	0.000253	0.000327	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	0.000252	0.000326	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	0.000252	0.000325	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	0.000249	0.000322	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—FADS1—Crohn's disease	0.000248	0.00032	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000243	0.000314	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000243	0.000314	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000242	0.000313	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—JAK2—Crohn's disease	0.000242	0.000312	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	0.000241	0.000312	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	0.000241	0.000311	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	0.00024	0.00031	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000239	0.000309	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	0.000238	0.000307	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000233	0.000301	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GPX4—Crohn's disease	0.000232	0.0003	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SMAD3—Crohn's disease	0.000229	0.000296	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	0.000229	0.000295	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	0.000228	0.000294	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	0.000226	0.000292	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GCKR—Crohn's disease	0.000224	0.00029	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TYK2—Crohn's disease	0.000221	0.000286	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	0.00022	0.000285	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	0.00022	0.000284	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	0.000219	0.000283	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	0.000217	0.00028	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000212	0.000275	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL2RA—Crohn's disease	0.000212	0.000274	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TYK2—Crohn's disease	0.000212	0.000274	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	0.000212	0.000274	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—JAK2—Crohn's disease	0.000211	0.000273	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	0.000211	0.000273	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	0.000209	0.00027	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—JAK2—Crohn's disease	0.000202	0.000261	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CXCL8—Crohn's disease	0.000193	0.000249	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CXCL8—Crohn's disease	0.000184	0.000238	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—IL6—Crohn's disease	0.000183	0.000237	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ALB—Crohn's disease	0.000182	0.000236	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL6—Crohn's disease	0.000175	0.000227	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTGS2—Crohn's disease	0.00016	0.000206	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ALB—Crohn's disease	0.000157	0.000203	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—STAT3—Crohn's disease	0.000155	0.0002	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ALB—Crohn's disease	0.000154	0.000199	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TYK2—Crohn's disease	0.00015	0.000193	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TYK2—Crohn's disease	0.000149	0.000193	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TYK2—Crohn's disease	0.000149	0.000192	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—STAT3—Crohn's disease	0.000148	0.000192	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TYK2—Crohn's disease	0.000147	0.00019	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—JAK2—Crohn's disease	0.000143	0.000184	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—JAK2—Crohn's disease	0.000142	0.000184	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—JAK2—Crohn's disease	0.000142	0.000183	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—JAK2—Crohn's disease	0.00014	0.000181	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTGS2—Crohn's disease	0.000137	0.000177	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTGS2—Crohn's disease	0.000134	0.000174	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ALB—Crohn's disease	0.000133	0.000172	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL8—Crohn's disease	0.00013	0.000168	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	0.00013	0.000168	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	0.000129	0.000167	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	0.000128	0.000166	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6—Crohn's disease	0.000124	0.00016	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6—Crohn's disease	0.000123	0.00016	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6—Crohn's disease	0.000123	0.000159	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6—Crohn's disease	0.000122	0.000158	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ALB—Crohn's disease	0.000119	0.000153	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTGS2—Crohn's disease	0.000116	0.00015	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ALB—Crohn's disease	0.000109	0.000141	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6—Crohn's disease	0.000108	0.00014	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ALB—Crohn's disease	0.000108	0.00014	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—STAT3—Crohn's disease	0.000105	0.000135	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—STAT3—Crohn's disease	0.000104	0.000135	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—STAT3—Crohn's disease	0.000104	0.000135	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTGS2—Crohn's disease	0.000104	0.000134	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6—Crohn's disease	0.000104	0.000134	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—STAT3—Crohn's disease	0.000103	0.000133	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTGS2—Crohn's disease	9.54e-05	0.000123	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTGS2—Crohn's disease	9.46e-05	0.000122	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6—Crohn's disease	7.32e-05	9.46e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6—Crohn's disease	7.29e-05	9.43e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6—Crohn's disease	7.27e-05	9.4e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6—Crohn's disease	7.2e-05	9.3e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ALB—Crohn's disease	7.13e-05	9.22e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTGS2—Crohn's disease	6.24e-05	8.06e-05	CbGpPWpGaD
